These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2996340)

  • 21. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are non-modulating patients with essential hypertension a distinct subgroup? Implications for therapy.
    Williams GH; Hollenberg NK
    Am J Med; 1985 Sep; 79(3C):3-9. PubMed ID: 2996343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension.
    Rosenthal T; Kissin E; Jacob ET; Stern N; Levi Y; Adar R
    Angiology; 1979 Feb; 30(2):123-8. PubMed ID: 434566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
    Bianchi MD; Fernandes M
    N Engl J Med; 1980 Jan; 302(3):179. PubMed ID: 6243169
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renin-angiotensin system blockers].
    Dimitrov T
    Eksp Med Morfol; 1982; 21(2):49-54. PubMed ID: 6183092
    [No Abstract]   [Full Text] [Related]  

  • 30. Renin inhibition: what are the therapeutic opportunities?
    Fisher ND; Hollenberg NK
    J Am Soc Nephrol; 2005 Mar; 16(3):592-9. PubMed ID: 15703270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.
    Waller PC; McInnes GT
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):769. PubMed ID: 3032326
    [No Abstract]   [Full Text] [Related]  

  • 32. [Angiotensin converting enzyme inhibitor perindopril in the treatment of patients with arterial hypertension and renal failure].
    Gapon LI
    Kardiologiia; 2010; 50(10):93-6. PubMed ID: 21118187
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibition: a new therapeutic modality.
    Gavras H; Charocopos F; Brunner H; Gavras I
    Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical implications of RAAS inhibition in patients on peritoneal dialysis.
    Guest S
    Nephrol News Issues; 2012 May; 26(6):42-5. PubMed ID: 22690459
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination renin-angiotensin system blockade in hypertension.
    Doulton TW; Macgregor GA
    Kidney Int; 2005 Oct; 68(4):1898. PubMed ID: 16164672
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 37. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal response to angiotensin-converting enzyme inhibition.
    Hollenberg NK
    Am J Cardiol; 1982 Apr; 49(6):1425-9. PubMed ID: 6176107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
    Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
    Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.